BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 38554155)

  • 1. Dendritic cell gene therapy.
    Onaitis M; Kalady MF; Pruitt S; Tyler DS
    Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 promotes expansion and intratumoral accumulation of tumor infiltrating dendritic cells in pancreatic cancer.
    Gong T; Huang X; Wang Z; Chu Y; Wang L; Wang Q
    Cancer Immunol Immunother; 2024 Mar; 73(5):84. PubMed ID: 38554155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
    Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
    J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin on functional status of cord blood-derived dendritic cells and on dendritic cell-induced CTL cytotoxicity against pancreatic cancer cell lines.
    Liu QL; Wang YS; Wang JX
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):529-34. PubMed ID: 19822498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CTLs by DCs pulsed with K-ras mutant peptide on the surface of nanoparticles in the treatment of pancreatic cancer.
    Tan G; Wang Z; Zhang X; Cai Z; Zhang J
    Oncol Rep; 2011 Jul; 26(1):215-21. PubMed ID: 21573499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer statistics, 2023.
    Siegel RL; Miller KD; Wagle NS; Jemal A
    CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized tumor vaccine for pancreatic cancer.
    Orr S; Huang L; Moser J; Stroopinsky D; Gandarilla O; DeCicco C; Liegel J; Tacettin C; Ephraim A; Cheloni G; Torres D; Kufe D; Rosenblatt J; Hidalgo M; Muthuswamy SK; Avigan D
    Cancer Immunol Immunother; 2023 Feb; 72(2):301-313. PubMed ID: 35834008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer.
    Ding Z; Li Q; Zhang R; Xie L; Shu Y; Gao S; Wang P; Su X; Qin Y; Wang Y; Fang J; Zhu Z; Xia X; Wei G; Wang H; Qian H; Guo X; Gao Z; Wang Y; Wei Y; Xu Q; Xu H; Yang L
    Signal Transduct Target Ther; 2021 Jan; 6(1):26. PubMed ID: 33473101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity.
    Raeber ME; Rosalia RA; Schmid D; Karakus U; Boyman O
    Sci Transl Med; 2020 Sep; 12(561):. PubMed ID: 32938795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis.
    Doleh Y; Lal LS; Blauer-Petersen C; Antico G; Pishvaian M
    Cancer Med; 2020 May; 9(10):3463-3476. PubMed ID: 32212262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Frequency of Ras Mutations in Cancer.
    Prior IA; Hood FE; Hartley JL
    Cancer Res; 2020 Jul; 80(14):2969-2974. PubMed ID: 32209560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells in cancer immunology and immunotherapy.
    Wculek SK; Cueto FJ; Mujal AM; Melero I; Krummel MF; Sancho D
    Nat Rev Immunol; 2020 Jan; 20(1):7-24. PubMed ID: 31467405
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.